Investigation of changes in apelin receptor mRNA and protein expression in the myocardium and aorta of rats with two-kidney, one-clip (2K1C) Goldblatt hypertension

Journal of Physiology and Biochemistry

Volumn 71, Issue 2, 2015, Pages 165-175

  Najafipour, Hamid ^a   Vakili, Abedin ^b   Shahouzehi, Beydolah ^c   Soltani Hekmat, Ava ^d   Masoomi, Yaser ^a   Yeganeh Hajahmadi, Mahbobeh ^c   Esmaeli Mahani, Saeed ^e  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Aorta; Apelin receptor; Gene expression; Heart; Renovascular hypertension

Indexed keywords

ANGIOTENSIN II; APLN PROTEIN, RAT; APLNR PROTEIN, RAT; G PROTEIN COUPLED RECEPTOR; SIGNAL PEPTIDE;

ANIMAL; AORTA; BLOOD; BLOOD PRESSURE; CARDIAC MUSCLE; DISEASE MODEL; GENETICS; HEART FAILURE; HEART VENTRICLE; KIDNEY; MALE; METABOLISM; PATHOPHYSIOLOGY; RENOVASCULAR HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; SURGERY; SURGICAL EQUIPMENT;

ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART VENTRICLES; HYPERTENSION, RENOVASCULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; MYOCARDIUM; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURGICAL INSTRUMENTS;

EID: 84939964522     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-015-0394-z     Document Type: Article

References (36)

1. Arnal JF, el Amrani AI, Chatellier G, Ménard J, Michel JB (1993) Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension 22:380–387
2. Ashley EA, Powers J, Chen M et al (2005) The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 65:73–82
3. Ashley E, Chun HJ, Quertermous T (2006) Opposing cardiovascular roles for the angiotensin and apelin signaling pathways. J Mol Cell Cardiol 41:778–781
4. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JA, Struhl K (2002) Short protocols in molecular biology. USA Wiley. doi:10.1002/0471140856.txa03as00
5. Badyal DK, Lata H, Dadhich AP (2003) Animal models of hypertension and effect of drugs. Indian J Pharmacol 35:349–362
6. Barnes G, Japp AG, Newby DE (2010) Translational promise of the apelin-APJ system. Heart 96(13):1011–1016
7. Chandrasekaran B, Dar O, McDonagh T (2008) The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail 10:725–732
8. Chun HJ, Ali ZA, Kojima JJ et al (2008) Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 118:3343–3354
9. Dai T, Ramirez-Correa G, Gao WD (2006) Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553:222–228
10. De Falco M, De Luca L, Onori N, Cavallotti I, Artigiano F, Esposito V, De Luca B, Laforgia V, Groeger AM, De Luca A (2002) Apelin expression in normal human tissues. In Vivo 16(5):333–336
11. De Mota N, Reaux-Le Goazigo A, El Messari S et al (2004) Apelin a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci U S A 101:10464–10469
12. Fukushima H, Kobayashi N, Takeshima H, Koguchi W, Ishimitsu T (2010) Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure. J Cardiovasc Pharmacol 55(1):83–88
13. Goldblatt H, Lynch J, Hanzal RF, Summerville WW (1934) Studies on experimental hypertension: the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59(3):347–379
14. Hashimoto T, Kihara M, Imai N et al (2007) Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis. Am J Pathol 171:1705–1712
15. Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, Sugaya T, Matsuzaki H, Yamamoto R, Shiota N, Okunishi H, Kihara M, Umemura S, Sugiyama F, Yagami K, Kasuya Y, Mochizuki N, Fukamizu A (2004) Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 279(25):26274–26279
16. Iwanaga Y, Kihara Y, Takenaka H, Kita T (2006) Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 41(5):798–806
17. Kannel WB (1996) Blood pressure as a cardiovascular risk factor: prevention and treatment. J Am Med Assoc 275:1571–1576
18. Kazemi-Bajestani SMR, Patel VB, Wang W, Oudit GY (2012) Targeting the ACE2 and apelin pathways are novel therapies for heart failure: opportunities and challenges. Cardiol Res Pract. doi:10.1155/2012/823193
19. Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF (2008) The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol 90:343–349
20. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK (1996) The progression from hypertension to congestive heart failure. J Am Med Assoc 275:1557–1562
21. Losano GA (2005) On the cardiovascular activity of apelin. Cardiovasc Res 65:8–9
22. Marone M, Mozzetti S, Ritis DD, Pierelli L, Scambia G (2001) Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sample. Biol Proced Online 3:19–25
23. Martinez-Maldonado M (1991) Pathophysiology of renovascular hypertension. Hypertension 17:707–719
24. Mitchell BM, Wallerath T, Forstermann U (2007) Animal models of hypertension. Methods Mol Med 139:105–111
25. Najafipour H, Ferrell WR (1993) Sympathetic innervation and β-adrenoceptor profile of blood vessels in the posterior region of the rabbit knee joint. Exp Physiol 78:625–637
26. Najafipour H, SoltaniHekmat A, Nekooian AA, Esmaeli-Mahani S (2012) Apelin receptor expression in ischemic and non-ischemic kidneys and cardiovascular responses to apelin in chronic two‐kidney–one‐clip hypertension in rats. Regul Pept 178:43–50
27. O’Carroll AM, Selby TL, Palkovits M, Lolait SJ (2000) Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 1492:72–80
28. O’Carrol AM, Lolait SJ, Harris LE, Pope GR (2013) The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis. J Endocrinol 219:R13–R35
29. Sadjadi J, Puttaparthi K, Welborn MB III, Rogers TE, Moe O, Clagett GP, Turnage RH, Levi M, Modrall JG (2002) Up regulation of autocrine-paracrine renin-angiotensin systems in chronic reno-vascular hypertension. J Vasc Surg 36(2):386–392
30. Soltani Hekmat A, Najafipour H, Nekooian AA, Esmaeli-Mahani S, Javanmardi K (2011) Cardiovascular responses to apelin in two-kidney–one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys. Regul Pept 172(1–3):62–68
31. Szokodi I, Tavi P, Földes G, Voutilainen-Myllylä S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysä J, Tóth M, Ruskoaho H (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91:434–440
32. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251:471–476
33. Xiao-Hua Y, Tang Z-B, Liu L-J, Qian H, Tang S-L, Zhang D-W, Tian G-P, Tang C-K (2014) Apelin and its receptor APJ in cardiovascular diseases. Clin Chim Acta 248(1):1–8
34. Zhang J, Ren CX, Qi YF, Lou LX, Chen L, Zhang LK, Wang X, Tang C (2006) Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats 79:1153–9
35. Zhong JC, Huang DY, Liu GF, Jin HY, Yang YM, Li YF, Song XH, Du K (2005) Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res 65(3):743–750
36. Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, Ghali JK, Liebson PR (2001) Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 104(7):779–782